NURO stock forecast
Our latest prediction for NeuroMetrix, Inc.'s stock price was made on the June 11, 2020 when the stock price was at 1.83$.
In the short term (2weeks), NURO's stock price should outperform the market by 5.36%. During that period the price should oscillate between -12.32% and +23.49%.
In the medium term (3months), NURO's stock price should outperform the market by 1.64%. During that period the price should oscillate between -41.17% and +60.39%.Get email alerts
Create a solid portfolio with NURO
About NeuroMetrix, Inc.
NeuroMetrix, Inc. is a healthcare company, which engages in the research, development, and trade of medical equipment and consumables. It offers an over-the-counter wearable therapeutic device for chronic pain, the Quell Health Cloud, DPNCheck, and pain management devices to treat chronic pain, nerve diseases, and sleep disorder. The company was founded by Shai N. Gozani in June 1996 and is headquartered in Woburn, MA.
At the moment the company generates 8M USD in revenues.
On its last earning announcement, the company reported a loss of -7.00$ per share.
The book value per share is 1.05$
Three months stock forecastJune 11, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|